Gender differences in the association of C-reactive protein with coronary artery calcium in Type-2 diabetes

Clinical Endocrinology

Volumn 74, Issue 1, 2011, Pages 44-50

  Qasim, Atif N ^a   Budharaju, Venkata ^b   Mehta, Nehal N ^a   St Clair, Caitlin ^a   Farouk, Samira ^a   Braunstein, Seth ^a   Schutta, Mark ^a   Iqbal, Nayyar ^a   Rader, Daniel J ^a,c   Reilly, Muredach P ^a,c  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIDIABETIC AGENT; C REACTIVE PROTEIN; CALCIUM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NICOTINIC ACID; TRIACYLGLYCEROL;

ADULT; AGED; ARTERY CALCIFICATION; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORONARY ARTERY; CORONARY ARTERY ATHEROSCLEROSIS; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DISEASE MARKER; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RACE DIFFERENCE; SCORING SYSTEM; SEX DIFFERENCE; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE;

EID: 78650370958     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2010.03879.x     Document Type: Article

References (37)

1. Libby, P., Ridker, P.M., &, Maseri, A., (2002) Inflammation and atherosclerosis. Circulation, 105, 1135-1143.
2. Musunuru, K., Kral, B.G., Blumenthal, R.S., et al. (2008) The use of high-sensitivity assays for C-reactive protein in clinical practice. Nature Clinical Practice. Cardiovascular Medicine, 5, 621-635.
3. Elliott, P., Chambers, J.C., Zhang, W., et al. (2009) Genetic Loci associated with C-reactive protein levels and risk of coronary heart disease. JAMA, 302, 37-48.
4. Devaraj, S., Singh, U., &, Jialal, I., (2009) The evolving role of C-reactive protein in atherothrombosis. Clinical Chemistry, 55, 229-238.
5. Zacho, J., Tybjaerg-Hansen, A., Jensen, J.S., et al. (2008) Genetically elevated C-reactive protein and ischemic vascular disease. New England Journal of Medicine, 359, 1897-1908.
6. Mazzone, T., Chait, A., &, Plutzky, J., (2008) Cardiovascular disease risk in type 2 diabetes mellitus: insights from mechanistic studies. Lancet, 371, 1800-1809.
7. Thorand, B., Lowel, H., Schneider, A., et al. (2003) C-reactive protein as a predictor for incident diabetes mellitus among middle-aged men: results from the MONICA Augsburg cohort study, 1984-1998. Archives of Internal Medicine, 163, 93-99.
8. Freeman, D.J., Norrie, J., Caslake, M.J., et al. (2002) C-reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland Coronary Prevention Study. Diabetes, 51, 1596-1600.
9. Ridker, P.M., Hennekens, C.H., Buring, J.E., et al. (2000) C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. New England Journal of Medicine, 342, 836-843.
10. Cushman, M., Arnold, A.M., Psaty, B.M., et al. (2005) C-reactive protein and the 10-year incidence of coronary heart disease in older men and women: the cardiovascular health study. Circulation, 112, 25-31.
11. Koenig, W., Lowel, H., Baumert, J., et al. (2004) C-reactive protein modulates risk prediction based on the Framingham Score: implications for future risk assessment: results from a large cohort study in southern Germany. Circulation, 109, 1349-1353.
12. Wang, T.J., Larson, M.G., Levy, D., et al. (2002) C-reactive protein is associated with subclinical epicardial coronary calcification in men and women: the Framingham Heart Study. Circulation, 106, 1189-1191.
13. Khera, A., de Lemos, J.A., Peshock, R.M., et al. (2006) Relationship between C-reactive protein and subclinical atherosclerosis: the Dallas Heart Study. Circulation, 113, 38-43.
14. Colhoun, H.M., Schalkwijk, C., Rubens, M.B., et al. (2002) C-reactive protein in type 1 diabetes and its relationship to coronary artery calcification. Diabetes Care, 25, 1813-1817.
15. Hunt, M.E., O'Malley, P.G., Vernalis, M.N., et al. (2001) C-reactive protein is not associated with the presence or extent of calcified subclinical atherosclerosis. American Heart Journal, 141, 206-210.
16. Redberg, R.F., Rifai, N., Gee, L., et al. (2000) Lack of association of C-reactive protein and coronary calcium by electron beam computed tomography in postmenopausal women: implications for coronary artery disease screening. Journal of the American College of Cardiology, 36, 39-43.
17. Lorenz, M.W., Karbstein, P., Markus, H.S., et al. (2007) High-sensitivity C-reactive protein is not associated with carotid intima-media progression: the carotid atherosclerosis progression study. Stroke, 38, 1774-1779.
18. Bowden, D.W., Lange, L.A., Langefeld, C.D., et al. (2005) The relationship between C-reactive protein and subclinical cardiovascular disease in the Diabetes Heart Study (DHS). American Heart Journal, 150, 1032-1038.
19. Khera, A., McGuire, D.K., Murphy, S.A., et al. (2005) Race and gender differences in C-reactive protein levels. Journal of the American College of Cardiology, 46, 464-469.
20. Lakoski, S.G., Cushman, M., Criqui, M., et al. (2006) Gender and C-reactive protein: data from the Multiethnic Study of Atherosclerosis (MESA) cohort. American Heart Journal, 152, 593-598.
21. Cartier, A., Cote, M., Lemieux, I., et al. (2009) Sex differences in inflammatory markers: what is the contribution of visceral adiposity? American Journal of Clinical Nutrition, 89, 1307-1314.
22. Reilly, M.P., Iqbal, N., Schutta, M., et al. (2004) Plasma leptin levels are associated with coronary atherosclerosis in type 2 diabetes. Journal of Clinical Endocrinology and Metabolism, 89, 3872-3878.
23. Valdes, A.M., Wolfe, M.L., Tate, H.C., et al. (2001) Association of traditional risk factors with coronary calcification in persons with a family history of premature coronary heart disease: the study of the inherited risk of coronary atherosclerosis. Journal of Investigative Medicine, 49, 353-361.
24. Qasim, A., Mehta, N.N., Tadesse, M.G., et al. (2008) Adipokines, insulin resistance, and coronary artery calcification. Journal of the American College of Cardiology, 52, 231-236.
25. Grundy, S.M., Cleeman, J.I., Daniels, S.R., et al. (2005) Diagnosis and management of the metabolic syndrome. An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Executive summary. Cardiology in Review, 13, 322-327.
26. Danesh, J., Wheeler, J.G., Hirschfield, G.M., et al. (2004) C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. New England Journal of Medicine, 350, 1387-1397.
27. Mora, S., Musunuru, K., &, Blumenthal, R.S., (2009) The clinical utility of high-sensitivity C-reactive protein in cardiovascular disease and the potential implication of JUPITER on current practice guidelines. Clinical Chemistry, 55, 219-228.
28. Kwok, S., Canoy, D., Ashton, W.D., et al. (2009) Increased C-reactive protein levels in overweight and obese women taking exogenous hormones: the United Kingdom Women's Heart Study (UKWHS). Clinical Endocrinology, 71, 727-732.
29. Saltevo, J., Vanhala, M., Kautiainen, H., et al. (2008) Gender differences in C-reactive protein, interleukin-1 receptor antagonist and adiponectin levels in the metabolic syndrome: a population-based study. Diabetic Medicine, 25, 747-750.
30. Hu, G., Jousilahti, P., Tuomilehto, J., et al. (2009) Association of serum C-reactive protein level with sex-specific type 2 diabetes risk: a prospective finnish study. Journal of Clinical Endocrinology and Metabolism, 94, 2099-2105.
31. Erbel, R., Mohlenkamp, S., Lehmann, N., et al. (2008) Sex related cardiovascular risk stratification based on quantification of atherosclerosis and inflammation. Atherosclerosis, 197, 662-672.
32. Reilly, M.P., Wolfe, M.L., Localio, A.R., et al. (2003) C-reactive protein and coronary artery calcification: The Study of Inherited Risk of Coronary Atherosclerosis (SIRCA). Arteriosclerosis, Thrombosis, and Vascular Biology, 23, 1851-1856.
33. Jenny, N.S., Brown, E.R., Detrano, R., et al. (2010) Associations of inflammatory markers with coronary artery calcification: results from the Multi-Ethnic Study of Atherosclerosis. Atherosclerosis, 209, 226-229.
34. Grundy, S.M., Cleeman, J.I., Merz, C.N., et al. (2004) Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation, 110, 227-239.
35. Brunzell, J.D., Davidson, M., Furberg, C.D., et al. (2008) Lipoprotein management in patients with cardiometabolic risk: consensus conference report from the American Diabetes Association and the American College of Cardiology Foundation. Journal of the American College of Cardiology, 51, 1512-1524.
36. Soinio, M., Marniemi, J., Laakso, M., et al. (2006) High-sensitivity C-reactive protein and coronary heart disease mortality in patients with type 2 diabetes: a 7-year follow-up study. Diabetes Care, 29, 329-333.
37. Elkeles, R.S., Godsland, I.F., Feher, M.D., et al. (2008) Coronary calcium measurement improves prediction of cardiovascular events in asymptomatic patients with type 2 diabetes: the PREDICT study. European Heart Journal, 29, 2244-2251.